 Amicus Therapeutics, Inc. NASDAQ:FOLD Q1 2022 Earnings Conference Call May 9, 2022 8:30 AM ET Company Participants Andrew Faughnan - Executive Director-Investor Relations John Crowley - Chairman and Chief Executive Officer Bradley Campbell - President and Chief Operating Officer Daphne Quimi - Chief Financial Officer Jeffrey Castelli - Chief Development Officer Conference Call Participants Ritu Baral - Cowen Anupam Rama - JPMorgan Ellie Merle - UBS Beth Feindt-Scott - SVB Leerink Kristen Kluska - Cantor Fitzgerald Dae Gon Ha - Stifel Salveen Richter - Goldman Sachs Yun Zhong - BTIG Operator Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics First Quarter 2022 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. 